CMS Ventures is an early-stage investment firm based in Cambridge, United Kingdom, established in 2020 as the corporate venture arm of China Medical System Holdings. The firm focuses on investing in the biotechnology and life sciences sectors, targeting seed-stage, early-stage, and later-stage startups within the UK. Through its investments, CMS Ventures aims to support innovative companies that are advancing healthcare solutions and contributing to the growth of the biotech industry.
Qureight is an imaging analytics company focused on enhancing the understanding of respiratory diseases, including Idiopathic Pulmonary Fibrosis and lung cancer. It develops a clinical data curation and analytics platform that integrates technology and life sciences to expedite drug development. By leveraging artificial intelligence, Qureight collaborates with hospitals, pharmaceutical companies, and software developers to analyze extensive clinical datasets. This approach aids in structuring medical images alongside clinical metadata, allowing healthcare professionals to identify novel biomarkers and deepen their comprehension of complex diseases and potential therapeutic strategies. The company is also working on a streamlined version of its analytical platform to further improve its capabilities in generating insights.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.